Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)
Invivyd posted quarterly Cash from Investing Activities of -$11000.0 for Q2 2025, up 92.36% on a QoQ basis from -$144000.0 in Q1 2025.
Invivyd (IVVD) has 5 years of Cash from Investing Activities data on file, last reported at -$11000.0 in Q2 2025.
- For the quarter ending Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$155000.0 (down 10.71% YoY), and the FY2025 full-year result was -$155000.0, down 10.71% from the prior year.
- Cash from Investing Activities for Q2 2025 stood at -$11000.0, up from -$144000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $137.9 million in Q4 2021 and bottomed at -$188.6 million in Q3 2021.
- The 5-year median for Cash from Investing Activities is -$5000.0 (2024), against an average of -$65933.3.
- The widest annual swing landed in 2022, when Cash from Investing Activities tumbled 200.65%; it then soared 191835.29% in 2023.
- A 5-year view of Cash from Investing Activities shows it stood at $137.9 million in 2021, then sank by 200.65% to -$138.8 million in 2022, then soared by 156.13% to $77.9 million in 2023, then tumbled by 99.99% to $5000.0 in 2024, then plunged by 320.0% to -$11000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$11000.0 (Q2 2025), -$144000.0 (Q1 2025), and $5000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -144,000.00 |
| Mar 31, 2025 | -144,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Dec 31, 2023 | 77.92 Mn |
| Dec 31, 2023 | 77.92 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Jun 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 32.60 Mn |
| Mar 31, 2023 | 75.04 Mn |
| Mar 31, 2023 | 75.04 Mn |
| Dec 31, 2022 | -138.81 Mn |
| Dec 31, 2022 | -138.81 Mn |
| Sep 30, 2022 | -140.84 Mn |
| Sep 30, 2022 | -140.84 Mn |
| Jun 30, 2022 | -17,000.00 |
| Jun 30, 2022 | -17,000.00 |
| Mar 31, 2022 | 49.00 Mn |
| Mar 31, 2022 | 49.00 Mn |
| Dec 31, 2021 | 137.92 Mn |
| Dec 31, 2021 | 137.92 Mn |
| Sep 30, 2021 | -188.63 Mn |
| Sep 30, 2021 | -188.63 Mn |